中国3-7月龄婴儿脑膜炎球菌疫苗接种的知识、认知与实践:全国横断面研究
2023年1月至2024年12月在中国29个省份开展横断面调查,纳入5069名接种点医护人员和148269名3-7月龄婴儿照护者。多数医护人员认识到脑膜炎球菌疾病负担,但99.4%对疾病预防表示不确定,主要因公众意识不足(85.3%)。照护者报告婴儿接种MPCV-ACYW后烦躁和哭闹更轻、总体安全性和耐受性优于MPCV-AC(各p<0.001)。
要点
- 99.4%的接种点医护人员对脑膜炎球菌疾病预防表示不确定,85.3%认为主要原因是公众意识不足。
- 选择自费脑膜炎球菌疫苗时,医护人员优先考虑保护效力(73.1%)和血清群覆盖(70.5%)。
- 照护者报告婴儿接种MPCV-ACYW后烦躁和哭闹更轻、总体安全性和耐受性优于MPCV-AC(各p<0.001)。
核心结论
- 本研究首次系统调查中国多省份医护人员和照护者对脑膜炎球菌疫苗接种的认知与实践,多数医护人员认可早期接种的必要性和MPCV-ACYW的有效性,结果提示需加强公众对脑膜炎球菌疾病的意识、实施针对性健康倡导并推广多价脑膜炎球菌疫苗。
研究设计与样本
- 2023年1月至2024年12月在中国29个省份开展的横断面调查,纳入5069名接种点医护人员和148269名3-7月龄婴儿照护者,通过结构化问卷收集疫苗知识、认知、偏好和接种实践数据。
主要发现
- 91.9%的医护人员认识到脑膜炎球菌疾病的沉重负担,但99.4%对疾病预防表示不确定,主要归因于公众意识不足(85.3%)。
- 选择自费脑膜炎球菌疫苗时,医护人员优先考虑保护效力(73.1%)和血清群覆盖(70.5%),与选择MPCV-ACYW的照护者优先考虑一致(78.2%)。
- 选择MPSV-A或MPCV-AC的照护者分别优先考虑安全性(42.2%和50.6%)和成本效益(52.6%和42.7%)。
- 照护者报告婴儿接种MPCV-ACYW后烦躁和哭闹更轻、总体安全性和耐受性优于MPCV-AC(各p<0.001)。
- 35.4%的婴儿首剂脑膜炎球菌疫苗与其他疫苗同时接种,同时接种模式因年龄和疫苗类型而异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meningococcal serogroup distribution evolves globally. In China, meningococcal polysaccharide vaccine (MPSV)-A is included in the National Expanded Program on Immunization (EPI) for infants at 6 months of age, while meningococcal polysaccharide conjugate vaccines (MPCV)-AC/ACYW are classified as non-EPI (self-paid) vaccines administered starting at 3 months of age. This study aimed to investigate the knowledge, perception, and practice of meningococcal vaccines among healthcare practitioners (HCPs) at points of vaccination (POVs) and caregivers of infants aged 3-7 months. METHODS: A cross-sectional survey was conducted between January 2023 and December 2024 across 29 provinces in China. A total of 5069 HCPs at POVs and 148,269 caregivers of infants aged 3-7 months were enrolled. Structured questionnaires were distributed to collect data on vaccine knowledge, perception, preferences, and vaccination practice. FINDINGS: Most HCPs (91·9 %) acknowledged the substantial burden of meningococcal disease. However, 99·4 % of HCPs reported uncertainty in meningococcal disease prevention, primarily due to insufficient public awareness (85·3 %). When selecting self-paid meningococcal vaccines, HCPs prioritized protective efficacy (73·1 %) and serogroup coverage (70·5 %), aligning with the priorities of caregivers choosing MPCV-ACYW (78·2 %). Conversely, caregivers choosing MPSV-A or MPCV-AC prioritized safety (42·2 % and 50·6 %, respectively) and cost-effectiveness (52·6 % and 42·7 %, respectively). Moreover, caregivers reported infants receiving the MPCV-ACYW experienced milder irritability and crying, and exhibited better overall safety and tolerability, compared to MPCV-AC (each p < 0·001). Additionally, 35·4 % of infants received simultaneous administration of their first-dose meningococcal vaccine and other vaccines. Simultaneous administration patterns of meningococcal vaccines and other vaccines differed by age and vaccine type. INTERPRETATION: This study is the first to systematically determine the perceptions and practices of meningococcal vaccination from both HCPs and caregivers across provinces in China. Most HCPs acknowledged the necessity of early meningococcal vaccination and MPCV-ACYW effectiveness. The findings indicate a need to strengthen public awareness of meningococcal disease, implement tailored health advocacy, and promote multivalent meningococcal vaccines.
引用
- Xia Y, Guo X, Fu X, et al. Knowledge, perception, and practice regarding meningococcal vaccination in infants 3-7 months of age: A nationwide cross-sectional study in China. Vaccine. 2025. PMID: 40714529. doi:10.1016/j.vaccine.2025.127542
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。